Dong-Hoon Shin

9PUBLICATIONS
14CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Sep 11, 2025
Targeting TGF-β-Smad2/3-JNK1-mediated SIRT1 activity overcomes the chemoresistance of KRAS mutation lung cancer.

Dong Hoon Shin, Minyoung Choi, Chungyong Han

|Oct 01, 2023
Oncogenic KRAS mutation confers chemoresistance by upregulating SIRT1 in non-small cell lung cancer.

Dong Hoon Shin, Jeong Yeon Jo, Minyoung Choi

|Jun 26, 2023
4-1BB-4-1BBL cis-interaction contributes to the survival of self-reactive CD8+ T cell.

Eunjung Cho, Rohit Singh, Chungyong Han

|Dec 24, 2021
Rapid Androgen-Responsive Proteome Is Involved in Prostate Cancer Progression.

Jong-Kwang Kim, Jae-Hun Jung, Dong-Hoon Shin

Pageof 2